Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115511
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115511
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115511
Table 4 Characteristics and main clinical findings on the ketogenic diet in colorectal cancer
| Ref. | Population/protocol | Dietary intervention | Clinical or therapeutic impact |
| Klement et al[117], 2021 | Recurrent stage IV colon cancer | Chemotherapy combined with a modified ketogenic diet | Response rate of 60%; disease control rate of 70%; complete response rate of 50%; trend toward longer overall survival in the responder group (50 months vs 32.5 months in the control group) |
| Egashira et al[118], 2023 | Rectal cancer | Ketogenic diet based on natural foods and standard diet during radiotherapy | Reduction in body weight and fat mass; preservation of skeletal muscle mass; tendency toward greater pathological tumor response (higher degree of Dworak regression and higher percentage of near-complete responses) |
- Citation: Lima RSP, Sousa JDS, Neres MSO, de Sousa DJM, Martins JA, Pereira IC, da Silva ACA, Severo JS, Torres-Leal FL, da Silva MTB. Colorectal cancer therapy and nutrition: From ultra-processed consumption to metabolic reprogramming. World J Gastrointest Oncol 2026; 18(4): 115511
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115511.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115511